Companies: 10,795·Total market cap: $144.5T

Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals, Ltd.

KNSANASDAQHealthcare● Active

$48.07

$-0.35(-0.72%)

Market Cap$3.6B

P/E Ratio—

52W High$59.87

52W Low$26.27

Avg Volume693K

Open$48.80

Beta0.12

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Kiniksa Pharmaceuticals, Ltd.（KNSA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KNSA · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.98Earnings history

PE Ratio (TTM)49.1×PE Ratio deep dive

Revenue (TTM)$754.0MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding74.2MShares outstanding history

Next EarningsJul 28, 2026Est.Earnings history

探索 Kiniksa Pharmaceuticals, Ltd. 数据

分析师预测$64 · Buy

股息不分红

营收$677.6M+60.09%

盈利EPS $0.80+233.33%

市盈率49.1×

财务快照

FY 2025Revenue$677.6M▲ +60.09% YoY

202320242025

FY 2025Net Income$59.0M▲ +236.61% YoY

202320242025

FY 2025EPS$0.80▲ +233.33% YoY

202320242025

TTM:Revenue: $754.0MNet Income: $73.1MEPS: $0.98View income statement →

分析师评级与目标价

Buy11 位分析师

Strong Buy

0

Buy

11

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$59.00Low

$48.07Current

$64.00Avg Target上涨空间 33.13%

$71.00High

合计: 11 · 买入占比: 100.0%

根据过去 3 个月内 11 位华尔街分析师，KNSA 共识评级为 Buy，12 个月平均目标价 $64.00 （较现价 $48.07 上涨空间 33.13%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Kiniksa Pharmaceuticals, Ltd.

$48.07-0.72%$3.6B #2

Adaptive Biotechnologies Corporation

$17.31-0.09%$2.8B #3

Apellis Pharmaceuticals, Inc.

$41.03+0.00%$5.3B #4

Cidara Therapeutics, Inc.

$221.38+0.00%$5.6B #5

Catalyst Pharmaceuticals, Inc.

$31.29+0.04%$3.8B #6

Amicus Therapeutics, Inc.

$14.49+0.00%$4.5B

股票表现

1D-0.59%

1W+1.53%

1M-17.86%

3M+4.28%

YTD+16.69%

1Y+58.70%

5Y+239.22%

关于 Kiniksa Pharmaceuticals, Ltd.

CEOSanj K. Patel

IPO DateMay 25, 2018

Employees315

CountryUS

Websitekiniksa.com

Kiniksa Pharmaceuticals, Ltd. a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases w…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Kiniksa Pharmaceuticals, Ltd.（KNSA）是 Biotechnology 行业的 Healthcare 类公司，于 May 25, 2018 在 NASDAQ 上市。截至最近交易日，KNSA 股价为 $48.07，市值约为 $3.6B。过去12个月累计回报 +58.70%，年初至今回报 +16.69%。

根据 11 位华尔街分析师，Kiniksa Pharmaceuticals, Ltd. 股票共识评级为Buy，12个月平均目标价为 $64.00。2025 财年 Kiniksa Pharmaceuticals, Ltd. 营收 $677.6M，净利润 $59.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Kiniksa Pharmaceuticals, Ltd.（KNSA）股价为 $48.07，在 NASDAQ 上市，52周区间为 $26.27 – $59.87。

KNSA 最新股价KNSA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议